Streetbeat News

Products Services

TSBX

Turnstone Biologics has reported presentations of preclinical data that highlight the potential for selected tumor-infiltrating lymphocyte therapy in solid tumors.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 10:09 am

XPEV

In response to complaints about the unavailability of its Navigation Guided Pilot (NGP) feature, Xpeng Motors is offering a 2,000 yuan voucher to P5 owners. The news was reported by China's National Business Daily.

Portfolio Pulse from Charles Gross

November 03, 2023 | 10:06 am

AAPL

QCOM

SSNLF

Samsung Electronics Co Ltd. is reportedly planning an early launch for its Galaxy S24 series on Jan. 17 in the US, in a bid to compete with Apple Inc.'s iPhone 15 series. The Galaxy S24 series will be powered by Qualcomm Inc.'s latest flagship chipset, the Snapdragon 8 Gen 3. Samsung is also expected to return to the US in 2024 to launch its new Galaxy Z Fold and Flip phones.

Portfolio Pulse from Rounak Jain

November 03, 2023 | 10:05 am

SBUX

Starbucks Corporation's new CEO, Laxman Narasimhan, has unveiled a long-term strategic plan called the 'Triple-Shot Reinvention Strategy'. The strategy focuses on enhancing the store experience, expanding digital capabilities, and increasing global outreach. The company expects this strategy to lead to a long-term revenue growth of 10% or more and an earnings per share growth of 15% or more. Starbucks also plans to operate 55,000 stores by 2030, a 45% increase from its current 38,000 stores.

Portfolio Pulse from Benzinga Neuro

November 03, 2023 | 9:34 am

NKLA

Nikola Corp (NASDAQ:NKLA) has outlined its strategy following a recall of all its battery electric trucks due to fire incidents caused by coolant leaks within the battery packs. The company plans to replace the battery packs in the existing BEVs with new packs from an alternative supplier. The upgraded vehicles, dubbed “2.0,” will feature improved battery packs, scheduled departure charging, enhanced human-machine interface (HMI), and Bluetooth functionality. They are set to be returned to customers starting in Q1 2024. Nikola anticipates increased costs over the next nine to 12 months related to the recall, leading to an additional capital requirement of approximately $400 million.

Portfolio Pulse from Anan Ashraf

November 03, 2023 | 8:51 am

QCOM

SSNLF

Qualcomm's CEO Cristiano Amon confirmed that Samsung's upcoming Galaxy S24 will feature both Exynos and Snapdragon chips. Last year's Galaxy S23 exclusively used Qualcomm's Snapdragon 8 Gen 2 chip, but Samsung has decided to return to offering models with different chipsets. The processors used in the Galaxy S24 will be determined by region, except for the S24 Ultra which will exclusively use a Qualcomm chip.

Portfolio Pulse from Benzinga Neuro

November 03, 2023 | 8:41 am

CHD

Church & Dwight Co Inc (NYSE:CHD) is expected to release its Q3 financial results on Nov. 3, 2023. Analysts predict earnings of 69 cents per share and revenue of $1.43 billion. The company recently initiated a voluntary recall of a product due to microbial contamination. The stock closed at $91.96, up 1.9%. Several analysts have updated their ratings and price targets for the company.

Portfolio Pulse from Lisa Levin

November 03, 2023 | 8:41 am

AMZN

Amazon (AMZN) has announced that diamond-certified country music artist Garth Brooks will headline the first Amazon Music Live Concert on Black Friday.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 6:57 am

TSLA

Elon Musk, CEO of Tesla Inc., discussed the future of jobs and the role of AI with UK Prime Minister Rishi Sunak. Musk believes that AI will eventually make all jobs obsolete, although he acknowledged the difficulty of predicting when this will occur. Sunak noted that AI has already created job opportunities and enhanced human capabilities. The conversation followed the AI Safety Summit, where tech companies and nations signed a voluntary agreement to allow governments to test their latest AI models for societal and national security risks.

Portfolio Pulse from Ananya Gairola

November 03, 2023 | 6:56 am

IPHA

Innate Pharma will present new clinical data for Lacutamab and SAR443579/IPH6101 at the American Society of Hematology 2023. This could potentially impact the company's stock performance depending on the results of the presentation.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 6:29 am